Tag: BASIL-2
Obituary: Roger M. Greenhalgh (Feb. 6, 1941–Oct. 6, 2023)
Roger Malcolm Greenhalgh, MD, the surgeon internationally renowned for his unparalleled contribution to vascular education, training and research, died peacefully on Oct. 6. He...
The top 10 most popular Vascular Specialist stories of June 2023
Last month, Vascular Specialist garnered readers' attention with an array of commentary on the BEST-CLI and BASIL-2 trials; the medical editor's interview with vascular...
VAM 2023 attendees have their say on the impact of BEST-CLI...
As the vascular community continues to unpack the key learnings from two of the biggest trials to date in chronic limb threatening ischemia—BEST-CLI and...
VAM attendees chime in on BEST-CLI and BASIL-2
VS@VAM journalist Will Date and videographer Jean-Philippe Bensoussan caught some VAM 2023 foot traffic outside the BEST-CLI and BASIL-2: Debate, Analysis and Implementation session...
Special VAM session underscores ‘complementary’ nature of open and endovascular strategies...
A dedicated session at VAM 2023 saw speakers and delegates gather to debate, analyse and consider the implementation of the BEST-CLI and BASIL-2 randomized-controlled...
BEST-CLI vs. BASIL-2: Different questions yield different answers
Medical editor Malachi Sheahan III, MD, takes a look at seemingly conflicting results from the landmark BEST-CLI and BASIL-2 trials, and asks what they...
BASIL-2 and BEST-CLI: A tale of two limb trials
Optimal treatment of patients with chronic limb-threatening ischemia (CLTI) has been an ongoing debate within the vascular community, fueled by growing numbers of patients,...
VAM 2023 beckons
Our annual gathering is almost here. After months of planning, our premiere educational event in vascular surgery, the Vascular Annual Meeting (VAM), opens June...
Vascular Specialist–June 2023 VAM special
In this VAM 2023 preview issue:
The Vascular Annual Meeting (VAM) beckons: "Our annual gathering is almost here. After months of planning, our premiere...
Vascular Specialist–May 2023
In this month's issue:
BASIL-2 points towards endovascular-first revascularization strategy in CLTI patients (p. 1 and 3)
A vascular mission: Defying assumptions in the...
BASIL-2 points towards endovascular-first revascularization strategy in CLTI patients
A question from Manj Gohel, MD, from Cambridge University Hospitals in Cambridge, England, on what the 2023 Charing Cross (CX) International Symposium audience should...
VAM educational sessions set to cover gamut of clinical and vascular...
With sessions covering a wide swath of topics important to vascular surgeons, including many proposed by Society for Vascular Surgery (SVS) members themselves, participants...
On 45th anniversary, CX Symposium chairman credits Chicago vascular surgical tandem...
The occasion of a seminal meeting held in Chicago by former Society for Vascular Surgery (SVS) Presidents John J. Bergan, MD, and James S.T....